Brief: Kintor Pharmaceutical Says CEO Bought 995,500 Shares Of Co In Open Market
29/07/2024 11:26
July 29 (Reuters) - Kintor Pharmaceutical Ltd 9939.HK :
* CEO VIA KT INTERNATIONAL INVESTMENT BOUGHT 995,500 SHARES
OF CO
IN OPEN MARKET FOR AGGREGATE OF HK$1.0 MILLION FROM JULY 19-25
Further company coverage: 9939.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kintor Pharmaceutical
See all newsBrief: Kintor Pharmaceutical Receives Invention Patent Grant For KT-939 In China
Brief: Kintor Pharmaceutical Says Ming Ming Cheung Resigns As CFO
Brief: Kintor Pharmaceutical Says CEO Via Wholly Owned Co Increases Shareholding By 2.51 Million Shares
Brief: Kintor Pharmaceutical Says YTD 2026 Sales Revenue At RMB34 Million
Brief: Kintor Pharmaceutical Says Pharma's Kx-826 Phase Iii Trial In China Reaches Primary Endpoint